Accumulating evidence has demonstrated that Fbxo45 exhibits a critical biological function in carcinogenesis and progression, indicating that targeting Fbxo45 may be a potential strategy for cancer therapy [18, 26]. This evidence concerns the gene FBXO45 and cancer.